(Q80015974)
Statements
Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers (English)
Hiroyuki Takase
Ai Nakazawa
Sumiyo Yamashita
Takayuki Toriyama
Koichi Sato
Ryuzo Ueda